Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eye prosthesis discomfort and discharge treatment comparison
NL-OMON59190Phase 4Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sodium hyaluronate and vitamin a in anophthalmic socket syndrome (ASS) and Chronic mucopurulent discharge of the ocular prosthesis socket (3 arms), sponsored by Amsterdam University Medical Center. Planned start Sep 2023; status: withdrawn.
02
Drugs
sodium hyaluronatevitamin a
03
Conditions
anophthalmic socket syndrome (ASS)Chronic mucopurulent discharge of the ocular prosthesis socket
Beyond the preview
Go deeper on NL-OMON59190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59190.